Apyx Medical (APYX) Interest Coverage Ratio Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 66.99% |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn | 69.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.99% |
| Dec 31, 2025 | 261.19% |
| Sep 30, 2025 | 76.82% |
| Jun 30, 2025 | 52.46% |
| Mar 31, 2025 | 53.21% |
| Dec 31, 2024 | 64.37% |
| Sep 30, 2024 | 67.95% |
| Jun 30, 2024 | -70.91% |
| Mar 31, 2024 | 80.24% |
| Dec 31, 2023 | 99.74% |
| Sep 30, 2023 | 99.86% |
| Jun 30, 2023 | 99.89% |
| Mar 31, 2023 | 96.73% |
| Dec 31, 2022 | -16.88% |
| Sep 30, 2022 | -337.15% |
| Jun 30, 2022 | 1.46% |
| Mar 31, 2022 | 38.13% |
| Dec 31, 2021 | -476.91% |
| Sep 30, 2021 | -656.50% |
| Jun 30, 2021 | -162.23% |
| Mar 31, 2021 | 5.00% |
| Dec 31, 2020 | 60.64% |
| Dec 31, 2019 | 74.46% |
| Dec 31, 2016 | 147.80% |
| Sep 30, 2016 | -104.25% |
| Jun 30, 2016 | -286.69% |
| Mar 31, 2016 | 2,413.45% |
| Dec 31, 2015 | -4,920.38% |
| Sep 30, 2015 | 681.92% |
| Jun 30, 2015 | 2,358.14% |
| Mar 31, 2015 | 26,759.89% |